SCHEMBL6497160

SCHEMBL6497160

CNc1cc[c]c(Cl)c1Cl

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1045149 0.73
SCHEMBL6963561 0.71 MAPT (0.41)
SCHEMBL2347098 0.69
SCHEMBL3788998 0.67 MAPT (0.44) HTR2AHTR2CHTR2B
SCHEMBL60891 0.67
SCHEMBL6256024 0.64
SCHEMBL9194651 0.64 GABRA1 (0.33) HTR2AHTR2C
SCHEMBL6505577 0.64 ALDH1A1 (0.33)
SCHEMBL6244342 0.64
SCHEMBL12816958 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed